Breakthrough Therapies: NTRK

Episode
98
Soundcloud
Share

In this episode of Lung Cancer Considered, host Dr. Narjust Duma talks with Dr. Robert C. Doebele, Co-Founder and Chief Scientific Officer, Rain Therapeutics about NTKR gene fusions, including recent and emerging breakthrough therapies.

Guest
Narjust Duma
Narjust Duma

MD

Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Robert C. Doebele
Robert C. Doebele
Co-Founder and Chief Scientific Officer, Rain Therapeutics